SPRY

NASDAQ 已收盘

ARS Pharmaceuticals

3.36 USD
▼-0.33-8.94%
盘后 3.15 -6.25%
2026-11-19
市值
$297.56M
市盈率
—
EPS
-2.01
股息率
—
52 周区间
2.44 – 13.15
成交量
3.65M
Beta
1.16
目标价
17.00
52W 低 2.4452W 高 13.15
价格走势

公司简介

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.